Managed Healthcare Executive November 11, 2020
MHE Staff

Pandemic prompts supply chain to focus on reducing risk, building resilience; concerns remain about data accuracy.

Supplyframe recently announced results of a medical device supply chain study, which indicates a gradual path to recovery for the MedTech industry over the next 18 months, according to a release. The study shares where the industry stands, what concerns still remain, and how to best build capacity in response to the global COVID-19 pandemic.

This research is based on a survey of 200 supply chain professionals who work at medical device companies based in North America. Conceptial Inc. conducted the research on behalf of Supplyframe between August and September of 2020. The survey gathered supply chain professionals’ sentiment during a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Supply Chain, Survey / Study, Technology, Trends
Spinoffs, sales and tuck-ins top medtech deal priorities: Moody’s
Bayer and ASPIVIX collaborate on women’s health device
STAT+: Medicare official says breakthrough device reimbursement rule coming in early summer
Brain-computer interface research reaches new frontiers
Opinion: STAT+: How AI can help satisfy FDA’s drug, device diversity requirements

Share This Article